Published in Gene on January 01, 1988
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol (1994) 11.55
Assembly of CENP-A into centromeric chromatin requires a cooperative array of nucleosomal DNA contact sites. J Cell Biol (1997) 3.62
A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07
Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J (1995) 2.92
CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J Cell Biol (2001) 2.72
Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J Virol (1999) 2.49
Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci U S A (1996) 2.18
Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J (1994) 1.53
Inducible human immunodeficiency virus type 1 packaging cell lines. J Virol (1996) 1.49
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest (1996) 1.49
Cadherins promote skeletal muscle differentiation in three-dimensional cultures. J Cell Biol (1997) 1.47
A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol (1994) 1.39
Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme. J Cell Biol (1998) 1.37
Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. Proc Natl Acad Sci U S A (1995) 1.37
Clathrin-coated pits with long, dynamin-wrapped necks upon expression of a clathrin antisense RNA. Proc Natl Acad Sci U S A (2003) 1.22
Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus. J Virol (1996) 1.19
Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med (1992) 1.17
The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol (1997) 1.15
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol Cell Biol (1995) 1.07
Generation of stable Drosophila cell lines using multicistronic vectors. Sci Rep (2011) 1.03
High-frequency intracellular transposition of a defective mammalian provirus detected by an in situ colorimetric assay. J Virol (1992) 1.00
Rearranging the centromere of the human Y chromosome with phiC31 integrase. Nucleic Acids Res (2005) 0.99
The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA. J Virol (1999) 0.92
Resistance to foot-and-mouth disease virus mediated by trans-acting cellular products. J Virol (1989) 0.91
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells. Mol Ther (2014) 0.89
Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J Virol (1995) 0.89
A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines. J Virol (2002) 0.87
RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo. J Virol (1997) 0.85
Complementarity-directed RNA dimer-linkage promotes retroviral recombination in vivo. Nucleic Acids Res (2004) 0.84
Toxin-antitoxin based transgene expression in mammalian cells. Nucleic Acids Res (2009) 0.83
Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83
Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites. Biochem J (1994) 0.83
Puromycin- and methotrexate-resistance cassettes and optimized Cre-recombinase expression plasmids for use in yeast. Yeast (2015) 0.76
Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines. Br J Cancer (1998) 0.76
Use of puromycin N-acetyltransferase (PAC) as a new reporter gene in transgenic animals. Nucleic Acids Res (1991) 0.76
Permanent cell lines that show temperature-dependent expression of adenovirus virus-associated RNA. J Virol (1989) 0.75
Selection for retroviral insertions into regulated genes. J Virol (1997) 0.75
A set of vectors for introduction of antibiotic resistance genes by in vitro Cre-mediated recombination. BMC Res Notes (2008) 0.75
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res (1986) 2.45
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene (1980) 2.44
Nucleotide sequence of the hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. Nucleic Acids Res (1986) 2.39
Ensemble asteroseismology of solar-type stars with the NASA Kepler mission. Science (2011) 2.28
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes. Biochim Biophys Acta (1978) 2.12
[Colonization/infection of pulmonary graft by Scedosporium inflatum]. Enferm Infecc Microbiol Clin (1997) 2.05
Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol (1994) 2.03
The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: implications for its involvement in mRNA transport. J Neurosci (1999) 2.03
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J (1999) 2.00
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. Gene (1980) 1.95
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res (1996) 1.89
Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem (1977) 1.87
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
Cryptopleurine resistance: genetic locus for a 40S ribosomal component in Saccharomyces cerevisiae. J Bacteriol (1974) 1.85
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol (1991) 1.82
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol (1997) 1.79
Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses. J Gen Virol (1993) 1.74
A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. Mol Cell Biol (1999) 1.74
The influenza A virus PB2 polymerase subunit is required for the replication of viral RNA. J Virol (1997) 1.71
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
Cloning and characterization of a cDNA encoding a protein synthesis initiation factor-2alpha (eIF-2alpha) kinase from Drosophila melanogaster. Homology To yeast GCN2 protein kinase. J Biol Chem (1997) 1.66
Ventilator-associated pneumonia with or without toothbrushing: a randomized controlled trial. Eur J Clin Microbiol Infect Dis (2012) 1.64
Evolution of the nucleotide sequence of influenza virus RNA segment 7 during drift of the H3N2 subtype. Gene (1983) 1.64
Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J Virol (1992) 1.61
Nuclear transport of influenza virus polymerase PA protein. Virus Res (1992) 1.59
[Diagnosis of obstructive sleep apnea syndrome. Consensus report from the Respiratory Insufficiency and Sleep Disorders Group]. Arch Bronconeumol (1995) 1.59
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res (1999) 1.57
Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle. EMBO Rep (2001) 1.55
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Molecular analysis of the pac gene encoding a puromycin N-acetyl transferase from Streptomyces alboniger. Gene (1989) 1.52
Flow cytometry and the study of central nervous disease in patients with acute leukaemia. Br J Haematol (2001) 1.52
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis (2001) 1.51
Phenotypic hiding: the carryover of mutations in RNA viruses as shown by detection of mar mutants in influenza virus. J Virol (1989) 1.50
Molecular cloning and sequencing of influenza virus A/Victoria/3/75 polymerase genes: sequence evolution and prediction of possible functional domains. Virus Res (1989) 1.49
pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol (1992) 1.48
The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res (1997) 1.48
Antioxidant systems and O(2)(.-)/H(2)O(2) production in the apoplast of pea leaves. Its relation with salt-induced necrotic lesions in minor veins. Plant Physiol (2001) 1.48
Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J Virol (1999) 1.47
Lung histopathological findings in fatal pandemic influenza A (H1N1). Med Intensiva (2011) 1.46
Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol (1996) 1.43
Comparative analysis of pediatric mailing lists on the Internet. Pediatrics (1997) 1.43
Heartburn and other related symptoms are independent of body mass index in irritable bowel syndrome. Rev Esp Enferm Dig (2010) 1.41
Lymphoma en cuirase. J Eur Acad Dermatol Venereol (2001) 1.40
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia (2004) 1.39
Quality of life in patients operated on for digestive neoplasia: a prospective study. Colorectal Dis (2012) 1.39
BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. Mediators Inflamm (1998) 1.39
Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit. J Virol (1996) 1.38
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res (1999) 1.32
Regulated M1 mRNA splicing in influenza virus-infected cells. J Gen Virol (1991) 1.28
Replication of orthomyxoviruses. Adv Virus Res (1999) 1.27
In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. J Gen Virol (1992) 1.26
Cloning and expression of a puromycin N-acetyl transferase gene from Streptomyces alboniger in Streptomyces lividans and Escherichia coli. Gene (1985) 1.26
Isolation and nucleotide sequencing of an aminocyclitol acetyltransferase gene from Streptomyces rimosus forma paromomycinus. J Bacteriol (1989) 1.24
The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res (1990) 1.24
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol (2005) 1.21
Degradation of cellular mRNA during influenza virus infection: its possible role in protein synthesis shutoff. J Gen Virol (1992) 1.19
Identification of cDNAS encoding plastid-targeted glutathione peroxidase. Plant J (1998) 1.19
Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J Gen Virol (1995) 1.18
Molecular cloning and expression in streptomyces lividans of a hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. Biochem Biophys Res Commun (1983) 1.17
Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ (2005) 1.13
In vitro synthesis of full-length influenza virus complementary RNA. EMBO J (1985) 1.13
Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin. J Med Genet (1994) 1.11
Optimization of gene expression in Streptomyces lividans by a transcription terminator. Nucleic Acids Res (1987) 1.10
Cross-links in African swine fever virus DNA. J Virol (1979) 1.10
The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta (1991) 1.10
Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). Gene (1985) 1.10
Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. J Virol (1996) 1.09
Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res (1995) 1.08
Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother (1995) 1.07
Genetic, phenotypic and clinical features of acute lymphoblastic leukemias expressing myeloperoxidase mRNA detected by RT-PCR. Leukemia (1999) 1.06
Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors. Biochemistry (1977) 1.05
Plant and fungal protein and glycoprotein toxins inhibiting eukaryote protein synthesis. Annu Rev Microbiol (1985) 1.04
Differential response of antioxidative enzymes of chloroplasts and mitochondria to long-term NaCl stress of pea plants. Free Radic Res (1999) 1.03
Biochemical basis of resistance to hygromycin B in Streptomyces hygroscopicus--the producing organism. J Gen Microbiol (1985) 1.03
Utility of home oximetry as a screening test for patients with moderate to severe symptoms of obstructive sleep apnea. Sleep (1999) 1.03
Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant. J Gen Virol (1993) 1.02
Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain. Proc Natl Acad Sci U S A (1994) 1.01
Roles for redox regulation in leaf senescence of pea plants grown on different sources of nitrogen nutrition. J Exp Bot (2006) 1.01
Inhibition of African swine fever (ASF virus replication by phosphonoacetic acid. J Gen Virol (1978) 1.00
Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J Virol (2000) 1.00
A trichodermin-resistant mutant of Saccharomyces cerevisiae with an abnormal distribution of native ribosomal subunits. Eur J Biochem (1980) 1.00
Severe hepatotoxicity due to anti-tuberculosis drugs in Spain. Int J Tuberc Lung Dis (2005) 0.99
In vivo reconstitution of active Thogoto virus polymerase: assays for the compatibility with other orthomyxovirus core proteins and template RNAs. Virus Res (1998) 0.99